Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)

Aurisco Pharmaceutical Revenue

Aurisco Pharmaceutical had revenue of 389.26M CNY in the quarter ending March 31, 2026, a decrease of -3.17%. This brings the company's revenue in the last twelve months to 1.68B, up 9.25% year-over-year. In the year 2025, Aurisco Pharmaceutical had annual revenue of 1.70B with 15.03% growth.

• Revenue (ttm): 1.68B
• Revenue Growth: +9.25%
• P/S Ratio: 5.31
• Revenue / Employee: 831.56K
• Employees: 1,784
• Market Cap: 8.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.70B	221.74M	15.03%
Dec 31, 2024	1.48B	213.21M	16.89%
Dec 31, 2023	1.26B	254.45M	25.24%
Dec 31, 2022	1.01B	204.71M	25.48%
Dec 31, 2021	803.36M	81.92M	11.36%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 8, 2026

Data Sources Report a data error